Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1
| Заболевание | Type 2 Diabetes |
|---|---|
| Фаза | Не применимо |
| Спонсор | State University of New York at Buffalo |
| Статус | Завершено |
| Участники | 450 участн. |
| Вмешательство | FINANCE-DM, Active Comparator |
| Дата начала | 1.12.2019 |
| Дата завершения | 30.06.2025 |
| Публикация результатов | 24.07.2026 |
Кратко
The objective of this protocol is to answer the questions: 1) Are financial incentives layered upon nurse education and home telemonitoring superior to nurse education and home telemonitoring alone in improving metabolic control long term? 2) Are the effects of financial incentives on metabolic control sustained once the incentives are withdrawn? and 3) Are financial incentives efficacious within and consistent across racial/ethnic groups? This study provides a unique opportunity to address these gaps in the literature. Investigators propose a randomized controlled trial to test the efficacy of a Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) intervention comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives; compared to an active control group (nurse education and home telemonitoring alone). The study also will evaluate whether intervention effects are sustained 6 months after the financial incentives are withdrawn (i.e. 18 months post randomization); and whether the intervention is differentially efficacious across racial/ethnic groups.
Glycemic Control (HbA1c)
| FINANCE-DM Intervention | 8.39 ± 1.67 mean percent HbA1c |
|---|---|
| TIDES Intervention | 8.61 ± 1.57 mean percent HbA1c |
Открыть в BENITIONS Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
- Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes — The Cleveland Clinic
- Diabetes Prevention Program Outcomes Study — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Uric Acid Lowering Trial in Youth Onset T2D — University of Colorado, Denver
- Continuous Glucose Monitoring Following Hospital Discharge — Kathleen Dungan
- Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on I — University of Colorado, Denver
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus — Eli Lilly and Company